|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 39/39 | (2006.01) |
| (11) | Number of the document | 2958588 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14706481.0 |
| Date of filing the European patent application | 2014-02-21 | |
| (97) | Date of publication of the European application | 2015-12-30 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/000461 |
| Date | 2014-02-21 |
| (87) | Number | WO 2014/127917 |
| Date | 2014-08-28 |
| (30) | Number | Date | Country code |
| PCT/EP2013/0005 | 2013-02-22 | WO |
| (72) |
FOTIN-MLECZEK, Mariola, DE
KALLEN, Karl-Josef, DE
PROBST, Jochen, DE
|
| (73) |
CureVac AG,
Paul-Ehrlich-Str. 15, 72076 Tübingen,
DE
|
| (54) | COMBINATION OF VACCINATION AND INHIBITION OF THE PD-1 PATHWAY |
| COMBINATION OF VACCINATION AND INHIBITION OF THE PD-1 PATHWAY |